Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Geron (GERN) Cash & Equivalents (2016 - 2025)

Geron's Cash & Equivalents history spans 16 years, with the latest figure at $1.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 97.62% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $1.9 million, down 97.62%, while the annual FY2025 figure was $1.9 million, 97.62% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $1.9 million at Geron, down from $78.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $116.9 million in Q2 2024 and bottomed at $363000.0 in Q3 2021.
  • The 5-year median for Cash & Equivalents is $31.0 million (2022), against an average of $36.0 million.
  • The largest annual shift saw Cash & Equivalents plummeted 99.36% in 2022 before it skyrocketed 21758.88% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $364000.0 in 2021, then surged by 15516.76% to $56.8 million in 2022, then rose by 23.18% to $70.0 million in 2023, then increased by 12.84% to $79.0 million in 2024, then crashed by 97.62% to $1.9 million in 2025.
  • Per Business Quant, the three most recent readings for GERN's Cash & Equivalents are $1.9 million (Q4 2025), $78.1 million (Q3 2025), and $77.7 million (Q2 2025).